IBOV 166,376.43 ▼ 0.69% COLCAP 2,452.46 — — IPC MEX 68,629.46 ▼ 0.12% MERVAL 2,848,945 — — USD/BRL5.91▼ 0.70% USD/MXN19.14▲ 0.30% USD/CLP 1,022 — 0.00% USD/COP3,483▲ 3.77% USD/PEN3.45▲ 0.19% USD/ARS1,580▲ 0.93% USD/UYU40.61▲ 3.16% USD/PYG6,212▲ 2.34% USD/BOB11.64▲ 2.55% USD/DOP59.52▼ 0.80% USD/CRC441.73▲ 2.68% USD/GTQ7.64▲ 3.22% USD/HNL26.89▲ 3.31% USD/NIO36.62▼ 0.69% USD/VES913.46▼ 0.45% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.59▲ 2.60% USD/TTD6.70▲ 2.00% EUR/BRL6.52▲ 1.12% BRENT 89.95 ▼ 2.21% WTI 83.41 ▲ 0.24% IRON ORE 161.91 — — COPPER 5.49 ▼ 2.49% GOLD 3,515 ▼ 4.62% SILVER 41.07 ▼ 7.33% SOY 1,221 ▲ 1.10% CORN 448.75 ▲ 2.22% WHEAT 592.00 ▲ 2.38% COFFEE 273.35 ▼ 3.08% SUGAR 17.07 ▼ 0.52% ORANGE JUICE 129.25 ▼ 2.49% COTTON 79.30 ▲ 4.41% COCOA 5,150 ▲ 1.72% BEEF 227.70 ▲ 2.18% CATTLE 335.43 ▼ 0.78% LITHIUM 51.98 ▼ 4.33% PETR4 42.67 ▼ 1.16% VALE3 58.48 ▼ 0.88% ITUB4 40.07 ▼ 0.30% BBDC4 13.83 ▼ 1.78% ABEV3 16.08 ▲ 0.06% BBAS3 14.30 ▲ 1.27% B3SA3 14.28 ▼ 0.14% WEGE3 51.13 ▼ 0.49% PRIO3 60.20 ▼ 2.70% SUZB3 55.32 ▼ 0.50% RENT3 28.86 ▼ 2.00% AZZA3 14.63 ▼ 7.29% CSAN3 3.08 ▼ 1.60% RAIZ4 15.00 ▼ 10.71% PCAR3 3.23 ▲ 8.03% GMAT3 4.18 ▲ 3.21% PSSA3 43.96 ▼ 1.57% CVCB3 0.72 ▼ 7.69% POSI3 3.37 ▲ 6.31% SLCE3 17.53 ▼ 1.96% NATU3 4.48 ▼ 6.28% BRKM5 2.60 ▼ 1.14% RANI3 8.01 ▼ 0.74% IBOV 166,376.43 ▼ 0.69% COLCAP 2,452.46 — — IPC MEX 68,629.46 ▼ 0.12% MERVAL 2,848,945 — — USD/BRL 5.91 ▼ 0.70% USD/MXN 19.14 ▲ 0.30% USD/CLP 1,022 — 0.00% USD/COP 3,483 ▲ 3.77% USD/PEN 3.45 ▲ 0.19% USD/ARS 1,580 ▲ 0.93% USD/UYU 40.61 ▲ 3.16% USD/PYG 6,212 ▲ 2.34% USD/BOB 11.64 ▲ 2.55% USD/DOP 59.52 ▼ 0.80% USD/CRC 441.73 ▲ 2.68% USD/GTQ 7.64 ▲ 3.22% USD/HNL 26.89 ▲ 3.31% USD/NIO 36.62 ▼ 0.69% USD/VES 913.46 ▼ 0.45% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.59 ▲ 2.60% USD/TTD 6.70 ▲ 2.00% EUR/BRL 6.52 ▲ 1.12% BRENT 89.95 ▼ 2.21% WTI 83.41 ▲ 0.24% IRON ORE 161.91 — — COPPER 5.49 ▼ 2.49% GOLD 3,515 ▼ 4.62% SILVER 41.07 ▼ 7.33% SOY 1,221 ▲ 1.10% CORN 448.75 ▲ 2.22% WHEAT 592.00 ▲ 2.38% COFFEE 273.35 ▼ 3.08% SUGAR 17.07 ▼ 0.52% ORANGE JUICE 129.25 ▼ 2.49% COTTON 79.30 ▲ 4.41% COCOA 5,150 ▲ 1.72% BEEF 227.70 ▲ 2.18% CATTLE 335.43 ▼ 0.78% LITHIUM 51.98 ▼ 4.33% PETR4 42.67 ▼ 1.16% VALE3 58.48 ▼ 0.88% ITUB4 40.07 ▼ 0.30% BBDC4 13.83 ▼ 1.78% ABEV3 16.08 ▲ 0.06% BBAS3 14.30 ▲ 1.27% B3SA3 14.28 ▼ 0.14% WEGE3 51.13 ▼ 0.49% PRIO3 60.20 ▼ 2.70% SUZB3 55.32 ▼ 0.50% RENT3 28.86 ▼ 2.00% AZZA3 14.63 ▼ 7.29% CSAN3 3.08 ▼ 1.60% RAIZ4 15.00 ▼ 10.71% PCAR3 3.23 ▲ 8.03% GMAT3 4.18 ▲ 3.21% PSSA3 43.96 ▼ 1.57% CVCB3 0.72 ▼ 7.69% POSI3 3.37 ▲ 6.31% SLCE3 17.53 ▼ 1.96% NATU3 4.48 ▼ 6.28% BRKM5 2.60 ▼ 1.14% RANI3 8.01 ▼ 0.74%
since 2009
Saturday, November 21, 2026

Africa Markets

Nigeria Wants 70% of Healthcare Products Made Locally

Nigeria buys most of its medicines and medical supplies abroad. The government now says it can reverse that by 2030 with cheap loans, tariff cuts and guaranteed state purchases.

By · · 6 min read
Bottles of liquid medicine moving along a pharmaceutical production line
Medicine bottles on a pharmaceutical production line. Nigeria wants most of its essential health products made at home by 2030

Key Facts

  • The country Nigeria is Africa’s most populous nation, with about 238 million people. Its economy was worth about US$291 billion in 2025, roughly 1 percent of the US economy (World Bank).
  • Why it matters Nigeria imports about 70 percent of its healthcare products, according to the head of a government programme. That leaves hospitals and patients exposed to foreign suppliers and a weak currency.
  • Why now On Monday 28 September 2026, Health Minister of State Iziaq Salako restated the 2030 goal at a drug makers’ expo in Lagos and gave new financing figures.
  • What happened Mr Salako said the government targets at least 70 percent local production of essential healthcare products by 2030, up from roughly 30 percent today.
  • The numbers He said a presidential programme has secured about US$2 billion in commitments at single-digit interest rates. Around 50 local health firms are in advanced funding talks.
  • What it means for you Foreign drug makers face pressure to build plants in Nigeria or partner locally. Investors gain tariff-free inputs and cheaper credit; patients may not see lower prices soon.
  • Still open The US$2 billion is commitments, not disbursed money. No public data yet tracks progress product by product.

Nigeria buys most of its medicines and medical supplies abroad. The government now says it can reverse that by 2030 with cheap loans, tariff cuts and guaranteed state purchases.

Free daily brief — no card needed
Get every Africa story in one morning email
We build you a personalized brief around the topics you follow — free for 7 days. Love it? Your first month after that is US$1.

Nigeria, Africa’s most populous country, is pushing for local healthcare production of at least 70 percent of its essential health products by 2030. Today it imports roughly 70 percent of what it needs.

Iziaq Salako, Minister of State for Health and Social Welfare, restated the goal on Monday 28 September 2026. He spoke in Lagos, the commercial capital, at the 8th Nigeria Pharma Manufacturers Expo.

A policy built on medicine security

The expo was organised by the drug makers’ group within the Manufacturers Association of Nigeria, the main industry lobby. Mr Salako framed local manufacturing as a question of national resilience and sovereignty.

He said the COVID-19 pandemic exposed how risky it is to rely on distant supply chains. Nigeria, he argued, must build capacity across the whole chain, not just final assembly.

The 2030 target is not new. Abdu Mukhtar, national coordinator of the government programme behind it, set out the same goal in a 2025 interview with the International Finance Corporation (IFC), the World Bank’s private-sector arm.

The money behind local healthcare production

That programme is the Presidential Initiative for Unlocking the Healthcare Value Chain, known as PVAC. Mr Salako said it has secured about US$2 billion in financing commitments at single-digit interest rates.

He added that about 50 Nigerian health firms are in advanced funding talks. Neither figure has been independently confirmed, and commitments are not the same as money paid out.

One concrete deal predates the speech. In June 2025, Afreximbank, the African Export-Import Bank, signed a US$75 million financing term sheet with Nigeria’s state-owned Bank of Industry.

That facility targets local makers of medicines, diagnostics, medical consumables and devices under PVAC. A term sheet sets out the terms of a loan; it is not yet a disbursement.

Tariff relief for drug makers

The second tool is tax. In June 2024, President Bola Tinubu signed an executive order removing tariffs and other levies on imported pharmaceutical machinery, ingredients and packaging inputs.

Mr Salako said 87 local manufacturers now benefit from that order. It covers almost 1,000 Harmonised System codes, the international categories customs officers use to classify goods.

On 1 October, Nigerian newspapers including The Guardian and The Nation reported that the government plans to extend the order. Local manufacturers had urged it to keep the relief in place.

Beyond drug assembly

Officials say the aim goes beyond packaging imported pills. The minister listed active pharmaceutical ingredients, vaccines, biologics and diagnostic tests among the products Nigeria wants to make itself.

He cited a new pilot centre for active ingredients at the National Institute for Pharmaceutical Research and Development, a state research body. He also mentioned efforts to make HIV, hepatitis and syphilis tests locally.

The third tool is demand. The government is setting up Medipool, a national group-purchasing body for essential medicines and medical supplies.

Medipool is meant to pool state orders and negotiate bulk buys. That should give local factories more predictable sales, which lowers the risk of building a plant without a buyer.

Who gains and who loses

Local manufacturers stand to gain most, especially the 87 firms using the tariff relief. Importers of finished medicines face a smaller market if the policy works.

Multinational drug companies face a choice: invest in Nigerian plants and partners, or lose ground to protected local rivals. Mr Salako also urged firms to target wider African markets under the African Continental Free Trade Area.

Patients are the open question. Nigerian newspapers reported in 2025 and 2026 that the 2024 tariff order had not stopped steep rises in drug prices.

In May 2026, pharmacists quoted by Punch, a Lagos newspaper, said the 2030 target was not feasible. Protected local producers may also end up more expensive than global suppliers.

What to watch next

The main risk is measurement. “Healthcare products” covers medicines, active ingredients, vaccines, diagnostics and devices, so the 70 percent goal is hard to track without yearly product data.

Watch whether Medipool starts buying, whether the tariff order is formally extended and whether the US$2 billion turns into actual loans. The 2030 deadline leaves just over four years.

Frequently Asked Questions

What is Nigeria’s local healthcare production target?

Nigeria’s government wants at least 70 percent of essential healthcare products made in the country by 2030. Today it imports roughly 70 percent of what it needs.

How much financing has Nigeria secured for drug makers?

Health Minister of State Iziaq Salako said on 28 September 2026 that about US$2 billion in commitments has been secured at single-digit interest rates. These are commitments, not money already paid out.

What is Medipool?

Medipool is a national group-purchasing body for essential medicines being set up by the Nigerian government. It is meant to pool state orders and give local manufacturers more predictable sales.

Will medicines get cheaper in Nigeria?

Not necessarily. Nigerian media report that drug prices kept rising despite a 2024 tariff-relief order, and local production must still compete on cost.

RT
Ask Rio Times
Latin American markets, currencies and companies.
Open the full Ask Rio Times →

Africa Intelligence

One email, every weekday morning. African markets, politics and business — filed from our newsroom in Rio.

Yesterday’s subject line: “South Africa's first woman deputy president dies at 71”

Connected Coverage

Sources

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

LatAm Markets: Live Signals → — real-time movers, turnover leaders and FX across Latin America.

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.